 SAN DIEGO, Oct. 8, 2021 PRNewswire -- Evofem Biosciences, Inc., NASDAQ: EVFM today commented on a letter from leaders in the House of Representatives to senior Biden Administration officials calling for action to ensure coverage for the full range of contraceptives under the Affordable Care Act ACA. I want to take a moment to praise our leaders in Washington who are working to make sure women have broad access to contraceptives, including new products like Phexxi that have been approved by the FDA since the ACAs passage, said Saundra Pelletier, Chief Executive Officer of Evofem. 